Mark Myron is an expert in the field of Hematology. He went to University of Kansas School of Medicine. He has 2 awards "Regional Top Doctor" and "Super Doctor". Mark Myron is also a published doctor. He has 2 publication published. The most recent publication is: The effect of tamoxifen or exemestane on bone mineral density during the first 2 years of adjuvant treatment of postmenopausal women with early breast cancer. He is registered with Medicare.
NPI NUMBER | 1902878309 | |
NPPES Provider LastName | MYRON | |
NPPES Provider FirstName | MARK | |
NPPES Provider ZIPCode | 662104045 | |
NPPES Provider State | KS | |
Specialty Description | Hematology/Oncology | |
Total Claim Count | 615.0 | |
Distinct Opioid Count | 4.0 | |
Opioid Claim Count | 100.0 | |
Percent Opioid Claims | 16.26 |
National Provider Identifier [NPI] | 1902878309 |
Last Name Of The Provider | MYRON |
First Name Of The Provider | MARK |
View All |
Dr. Gregory J. Crane, MD
This Doctor is OpenDoctor Recommended. |
|
Brooke Loo, PA
This Doctor is OpenDoctor Recommended. |
|
Dr. Galen M. Custer, MD
This Doctor is OpenDoctor Recommended. |
|
Dr. Laxmidas A. Sawkar, MD
This Doctor is OpenDoctor Recommended. This doctor has more publications |
|
Barry S. Skikne, MB CHB
This Doctor is OpenDoctor Recommended. This doctor has more publications |
|
Dr. Joseph Stilwill, MD
This Doctor is OpenDoctor Recommended. |
|
Dr. Elizabeth W. Ng, MD
This Doctor is OpenDoctor Recommended. |